Meyer R. Rosen, Editor-in-Chief
President, Interactive Consulting Inc.
Mr. Rosen is a Chartered Chemist and Fellow of the Royal Society of Chemistry (London); a Fellow of the American Institute of Chemists and both a Nationally Certified Professional Chemist and Certified Professional Chemical Engineer. He is a member of the U.S. Society of Cosmetic Chemists (SCC) & the American Institute of Chemical Engineers. Meyer serves as an Advisor for David Smith, Executive Director of the SCC Advisory Committee. He is also Editor for U.S. & Canada and Editor-in-Chief for North and Latin America for EuroCosmetics Magazine in Germany. Mr. Rosen is Editor of the Delivery System Handbook for Personal Care and Cosmetic Products and Editor-in-Chief of Harry’s Cosmeticology, 9th Edition.

Wednesday, June 27, 2012

Skin Ingredients, Ronni Weinkauf, Neostrata Company, Harry's Cosmeticology 9th ed.,

Ronni L. Weinkauf, Ph.D.

VP, Global Research & Development
NeoStrata Company, Inc., Princeton, NJ

Ronni Weinkauf, VP of NeoStrata’s Global Research and Development team, began her career with Unilever R&D in 1993 as a Research Scientist in the Clinical Research and Appraisal department.  Through her nearly 15 year tenure with Unilever, Ronni not only lead the Clinical Research team and the Skin Cleansing and Care clinical program, but also held senior Program management roles within the Skin Cleansing and Skin Care Research Program.  Ronni was Global Anti-Aging Program Director, leading all anti-aging and anti-irritant research efforts in the US, Europe and Asia.  

Ronni’s program delivered numerous patent protected new technologies, products, claims, driving growth for the Pond’s, Dove, as well Elizabeth Arden brands.  In 2007, Ronni joined the NeoStrata Company as VP of Research & Development and an executive member of NeoStrata’s leadership team.  The NeoStrata company, is a dermatology based skin research & development company.  The founders of NeoStrata pioneered and patented the use of Alpha Hydroxy Acids for the treatment and reversal of Aging Skin.  The NeoStrata company continues to identify and develop new generation anti-aging technology for both the NeoStrata branded products as well as partnership within the industry.  As VP of Global Research & Development, Ronni leads new technology development and product development programs which support the company’s NeoStrata dermatologist dispensed, and Exuviance and CoverBlend retail brands sold around the world in over 80 countries. 

Ronni has a broad based research expertise in skin structure, function, and repair, primarily in the areas of skin photodamage and repair, skin lightening, skin inflammation.  Ronni holds 13 US patents, 16 international patents, and has authored numerous scientific publications, poster presentations, as well as co-authoring book chapters and serving as invited speakers at cosmetic scientific conferences.  Ronni received her Bachelors of Science degree in Chemistry from the University of Delaware, and her Ph.D. in Medicinal Chemistry from Rutgers, the State University of New Jersey.

Global Clinical Leader
Unilever R&D USA, Trumbull, CT

Stacy Hawkins, Unilever Global Clinical Leader, Skin R&D Program began her career with Unilever R&D in 1996 as a research scientist and group leader of the Clinical Instruments Group in the Clinical Research and Skin Appraisal department.  As Global Clinical leader she develops and delivers global clinical testing plans for the Skin R&D program.  Her current responsibilities include development and execution of Unilever’s global publication strategy for skin research journals, key dermatology and industry conferences, and medical and educational materials.  She is also responsible for linking key research external collaborations to Unilever brand and educational activities.

Her research expertise includes: understanding wrinkle morphology and repair with anti-aging therapies; quantifying elasticity of the skin; clinical and consumer measurement of skin color and texture; role of skin barrier in maintenance of skin health.  Her research has been published in various skin bioengineering and dermatological publications, and has been used for novel claims substantiation for Pond’s and Dove skin care products.  These publications led to articles featured in Skin & Aging and Dermatology Times, as well as several invited talks and book chapters.  In addition, she serves on the Executive Committee of the International Society for Biophysics and Imaging of the Skin.  She received her Bachelors of Science degree from Massachusetts Institute of Technology in BioElectrical Engineering, and her Ph.D. from Rutgers, the State University of New Jersey, in Biomedical Engineering.

Uma Santhanam, Ph.D.
Senior Manager, Cell Biology and In Vitro Toxicology
Avon Products, Inc. Suffern NY 10901


Uma Santhanam joined Avon in 2004 and is a Senior Manager in Avon’s Cell Biology and In Vitro Toxicology group.  In this role, she manages new technology identification, in vitro safety and efficacy testing of ingredients and formulations, and helps create and substantiate novel claims for Avon skin care products. Using her extensive skin biology background and cutting-edge scientific approaches, Dr. Santhanam has helped develop several breakthrough anti-aging skin care products.    Prior to joining Avon, she worked as a Project Leader/Lead Research Scientist in Unilever Research US in New Jersey.  Her research interests include skin aging, photodamage and its repair, skin pigmentation, and inflammation.   

Dr. Santhanam holds a Microbiology and Ph.D in Biochemistry from University of Bombay, India.  She completed her post-doctoral training at The Rockefeller University in New York.  Dr. Santhanam holds a total of fourteen U.S. patents and over twenty international patents in the field of skincare.   She also has several US and International patents pending.  Dr. Santhanam has over twenty scientific publications, over thirty poster presentations and has authored a chapter in the book Biotechnology in Personal Care, Cosmetic Science and Technology Series, Taylor and Francis, New York, NY, 2004.   Dr. Santhanam was recognized for her work at Avon with several awards including The Avon Chairman’s Award  (2010), Excellence In Execution Award (2010) ,  Matrix Award (2010) and Global R&D Achievement Award (2006, 2007).  

Peter Konish
Director, Sensory and Formulation Development
NeoStrata Company, Inc

Peter Konish is the Director of Sensory and Formulation Development at NeoStrata Company, Inc.  Peter is responsible for the development of novel skin care formulations incorporating the use of alpha hydroxy acids (ie glycolic & lactic acids), polyhydroxy acids (ie gluconolactone), bionic acids (ie lactobionic & maltobionic acids), and aminosugars for the NeoStrata®, Exuviance®, and CoverBlend® skin care brands. Prior to this, Peter was at L’Oreal where he held the position of Manager of Fine Fragrance Ancillary Development. 

In this role, Peter was responsible for overseeing the development of skin care and body care formulations to support the Ralph Lauren, Kiehls, and LancĂ´me brands. Peter also has a strong background in polymer chemistry and started out his career at Amerchol Corporation where he researched the synthesis and application of various natural polymers derivatives using Chitin, Chitosan, Starch, Guar, and Cellulose for the skin care and hair care industries. Peter has co-authored numerous scientific articles in the Journal of Cosmetic Science, Macromolecules and in the ACS series of Polysaccharide Applications, Volume 737. He has been in the personal care industry for over 18 years and has extensive experience in skin care product development. Peter holds a B.S in Chemistry from Monmouth University, a M.S in Cosmetic Science from Fairleigh Dickinson University, and is an active member of the New York Chapter of the SCC.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Chemistry News